Gold and silver experienced significant rallies in 2025, with gold rising 82 and silver surging 175 on the MCX, overshadowing equity markets. The Nifty 50 and BSE Sensex saw modest gains of 10% and 9% respectively, with mid-cap and small-cap stocks underperforming large-caps. Despite market uncertainty, three micro-cap stocks, including Strides Pharma Science Ltd, are identified as potential outperformers for 2026 based on technical analysis, suggesting a shift in investment opportunities.